Ercha Shangqing pills | China Drugs List

Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.

Company
Hubei Qijin Pharmaceutical Co., Ltd.
Medicine type
Traditional Chinese medicine
Therapeutic area
Anesthesia & pain
Indications recorded in the public source
TCM actions: clears heat and fire, resolves toxicity, promotes healing of ulcers and relieves pain. For minor recurrent aphthous ulcers with the TCM pattern of excess heat in the upper burner. Symptoms include mouth or tongue ulcers, painful ulcers, thirst, a sticky sensation in the mouth, bad breath, a red tongue with a yellow or yellow-greasy coating, and a wiry-surging or wiry-rapid pulse.
Indication source and scope
Source date(s): 2024, 2026. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label.
Prescribing-information limitations
Indications checked against an official public submission. The full original prescribing information is still unavailable.
China availability status
Historical Chinese approval verified; current continuous market availability has not been checked for every product.
Overseas status
Market-by-market verification pending.
Insurance classification
Included in national insurance (Category B)
Insurance edition
2025 edition; effective 1 January 2026
Insurance restrictions
TCM actions: clears heat and fire, resolves toxicity, promotes healing of ulcers and relieves pain. For minor recurrent aphthous ulcers with the TCM pattern of excess heat in the upper burner. Symptoms include mouth or tongue ulcers, painful ulcers, thirst, a sticky sensation in the mouth, bad breath, a red tongue with a yellow or yellow-greasy coating, and a wiry-surging or wiry-rapid pulse.
Insurance period
2025-01-01 to 2026-12-31
Insurance verification notes
Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

Sources

Open the interactive record, public price references and discussions